Eppendorf AG Announces It Has Received Connecticut State Approval to Conduct Biosafety Level 2 Infectious Disease Related Research
10/21/2013 9:38:51 AM
ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly expands the capabilities of the Eppendorf Research and Development Laboratory located at their Enfield facility, and enhances research plans and activities for customers. “We plan to further our research in stem cell bioprocess to include induced pluripotent stem cells (IPSCs)” stated Dr. Ma Sha, Director, Technical Applications. “We are also actively seeking industry or industry/academia collaborations in the stem cell bioprocess area.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by